High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity …

MM Poulsen, PF Vestergaard, BF Clasen, Y Radko… - Diabetes, 2013 - Am Diabetes Assoc
… single study, only a limited number of human clinical trials of … present study we tested the
impact of high-dose resveratrol … energy and substrate metabolism, insulin sensitivity, ectopic fat

[PDF][PDF] An investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition

MM Poulsen, PF Vestergaard, BF Clasen, Y Radko… - Diabetes, 2013 - findresearcher.sdu.dk
High-dose resveratrol supplementation in obese men: An … the present study we tested the
impact of high-dose resveratrol … energy and substrate metabolism, insulin sensitivity, ectopic fat

The effects of resveratrol supplementation in overweight and obese humans: a systematic review of randomized trials

J Christenson, SJ Whitby, D Mellor… - Metabolic syndrome …, 2016 - liebertpub.com
randomized, double-blind, placebo-controlled human trials … , lipid profile changes, and
body composition, 13,24–27 yielding … the metabolic effects of high-dose resveratrol in obese

No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: A randomized trial

M de Ligt, M Bergman, RM Fuentes… - … journal of clinical …, 2020 - academic.oup.com
… Pre- and postintervention, energy expenditure and substraterandomized, placebo-controlled,
parallel-group clinical trial, … effects of resveratrol on body composition compared with …

[HTML][HTML] … trans-resveratrol on insulin resistance, inflammation, and microbiota in men with the metabolic syndrome: A pilot randomized, placebo-controlled clinical trial

JM Walker, P Eckardt, JO Aleman… - … translational research, 2019 - ncbi.nlm.nih.gov
… acetylate and activate or deactivate many substrates, including Forkhead transcription factor
study was to determine if high dose RES, administered to obese men with insulin resistance

… resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial

J Most, S Timmers, I Warnke… - … journal of clinical …, 2016 - academic.oup.com
… , we found that body weight and body composition were not … +RES supplementation
significantly affected fasting substrate … This is in agreement with other placebo-controlled trials in …

High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men

S Dash, C Xiao, C Morgantini, L Szeto… - … , and vascular biology, 2013 - Am Heart Assoc
insulin sensitivity in nondiabetic, overweight, and obese men … and the liver, respectively, in
overweight and obese men with … This would result in reduced substrate for VLDL triglyceride …

… supplementation on anthropometric indices, metabolic parameters, and serum sirtuin-1 levels in patients with nonalcoholic fatty liver disease: a randomized controlled …

S Asghari, M Asghari-Jafarabadi, MH Somi… - Journal of the …, 2018 - Taylor & Francis
… The study was designed as a randomized, placebo-controlled … in circulating glucose and
insulin sensitivity with 150 mg/d resveratrol consumption in healthy obese men after 30 days. In …

Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion

M Méndez-del Villar, M González-Ortiz… - Metabolic syndrome …, 2014 - liebertpub.com
… A randomized, double-blind, placebo-controlled clinical trial … the resveratrol group, 10 patients
were female and one male. … the effect of resveratrol on body weight, fat mass, BMI, and WC …

No beneficial effects of resveratrol on the metabolic syndrome: a randomized placebo-controlled clinical trial

TN Kjær, MJ Ornstrup, MM Poulsen… - … & Metabolism, 2017 - academic.oup.com
… , body composition, and lipid deposition in the liver or striated … on insulin sensitivity, lipids,
inflammation, BP, and hepatic fat … dose as the high-dose treatment in the current study, which is …